Focal Epilepsy study: ActivaDose II
Official title Study of Transcranial Direct Current Stimulation to Treat Epilepsy
ClinicalTrials.gov ID: NCT05673915
What this study is testing
- What it's testing
- The study wants to find out whether transcranial direct current stimulation can reduce the number and intensity of seizures.
- Who it's for
- People who have focal epilepsy, generalized onset epilepsy, or sleep‑related epileptic encephalopathy.
- What's involved
- Participants will receive transcranial direct current stimulation applied to the scalp during study visits, along with monitoring of seizure activity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 and older
You may be able to join if
- Clinical diagnosis of generalized onset or focal epilepsy or sleep-related epileptic encephalopathy.
- Estimated to have at least 2 countable seizures per month or spike-wave index ≥50%.
- Has not had control with at least 2 anti-seizure medicines.
- Able to maintain a constant medication for duration of the study (rescue meds allowed).
- Subject or legally authorized representative is able to understand consent and keep a seizure diary in English.
You likely can't join if
- A disease likely to progress over course of the study.
- Psychogenic non-epileptic seizures.
- Suicide attempt or psychiatric hospitalization past 2 years.
- A skin condition interfering with scalp electrodes or allergy to silver.
- Women will verify not pregnant, and if applicable, have a serum pregnancy test.
- Implanted devices (e.g. pacemakers)-except VNS, which is allowed.
The study team makes the final eligibility decision.
Where it is enrolling
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rochester, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.